Abnormal Development of Intestinal Intraepithelial Lymphocytes and Peripheral Natural Killer Cells in Mice Lacking the IL-2 Receptor beta  Chain

By Haruhiko Suzuki,Dagger § Gordon S. Duncan,* Hiroaki Takimoto,Dagger § and Tak W. Mak*Dagger §

From the * Amgen Institute, Dagger  Ontario Cancer Institute, and § Departments of Medical Biophysics and Immunology, University of Toronto, Toronto, Ontario, Canada M5G 2C1

Summary
Materials and Methods
Results and Discussion
Footnotes
Acknowledgements
References


Summary

The interleukin-2 receptor beta  chain (IL-2Rbeta ) is expressed on a variety of hematopoietic cell types, including natural killer (NK) cells and nonconventional T lymphocyte subsets such as intestinal intraepithelial lymphocytes (IEL). However, the importance of IL-2Rbeta -mediated signaling in the growth and development of these cells has yet to be clearly established. We have investigated IEL and NK cells in mice deficient for IL-2Rbeta and describe here striking defects in the development of these cells. IL-2Rbeta -/- mice exhibited an abnormal IEL cell population, characterized by a dramatic reduction in T cell receptor alpha beta CD8alpha alpha and T cell receptor gamma delta lymphocytes. This selective decrease indicates that IEL can be classified into those whose development and/or differentiation is dependent on IL-2Rbeta function and those for which IL-2Rbeta -mediated signaling is not essential. NK cell development was also found to be disrupted in IL-2Rbeta -deficient mice, characterized by a reduction in NK1.1+CD3- cells in the peripheral circulation and an absence of NK cytotoxic activity in vitro. The dependence of NK cells and certain subclasses of IEL cells on IL-2Rbeta expression points to an essential role for signaling through this receptor, presumably by IL-2 and/or IL-15, in the development of lymphocyte subsets of extrathymic origin.


The cytokine interleukin-2 (IL-2) and its receptor (IL2R) have long been known to play a role of prime importance in the activation and proliferation of T lymphocytes (reviewed in reference 1). However, it is unclear whether signaling via the IL-2R is required for the normal development and differentiation of other lymphoid or myeloid cells. The IL-2R is expressed on T lymphocytes (1), B cells (2), NK cells (3), neutrophils (4), and monocytes (5). The high affinity IL-2R is composed of three subunits, the alpha , beta , and gamma  chains, whereas the intermediate affinity form contains only the beta  and gamma  chains (6, 7). Components of the IL-2R have been identified in other cytokine receptors: the IL-2Rgamma chain (gamma c, or common gamma  chain) is common to the IL-2, IL-4, IL-7, IL-9, and IL-15 receptors, whereas the IL-2Rbeta chain is shared between the IL-2 and IL-15 receptors (8).

The importance of individual IL-2R chains in signal transduction has been clarified recently by the engineered deletion of the gene product for each of the three known receptor subunits. Given the diverse nature of the cytokine receptors that contain the beta  and gamma  chains, and the wide range of cell types that express components of the IL-2R, the disruption of multiple immunomodulatory roles might be expected in mice deficient for any one of the three subunits. Mice deficient in IL-2Ralpha exhibit polyclonal T and B cell expansion (9), which correlates with a defect in activation-induced cell death in T cells, and the development of autoimmune disorders and inflammatory bowel disease. Similarly, in IL-2Rbeta -deficient mice, T cells are spontaneously activated, resulting in plasma cell accumulation and high levels of autoantibodies (10). IL-2Rgamma -deficient mice also show a defect in mature T and B cell development, but in contrast with the lymphoproliferation seen in IL-2Ralpha - and IL-2Rbeta -deficient mice, a 10-fold reduction in absolute lymphocyte numbers is observed (11). In addition, NK cells are completely absent in IL-2Rgamma -deficient mice, and the number of intestinal intraepithelial cells (IEL)1 cells is severely diminished (11). In humans, loss of the gamma c function leads to X-linked severe combined immunodeficiency (SCID) (12), a disease characterized by multiple defects in T, NK, and B cell development, as might be expected from the impairment of several cytokine receptors (13). Thus, signaling via components of the IL-2R plays an essential regulatory role in homeostasis and autoimmunity.

The importance of IL-2 and IL-15 in NK cell activation and proliferation has been well documented (1, 8, 14). Because both cytokines signal via receptors containing the beta  and gamma  chains, and because IL-2Rgamma -deficient mice exhibit profound defects in IEL and NK cell development, it was of interest to examine the role of IL-2Rbeta in these lymphocyte populations. We report here that expression of IL-2Rbeta is crucial for the normal development of both TCRgamma delta and TCRalpha beta CD8alpha alpha IEL and for NK cells. These results suggest that certain cell populations that undergo extrathymic development and differentiation have an important developmental requirement for either IL-15 and/or IL-2.


Materials and Methods

Mice. Mice deficient in IL-2Rbeta were generated as previously described (10) and maintained under specific pathogen-free conditions in our animal facility. Littermate controls were used within experiments. Because IL-2Rbeta -deficient mice develop severe autoimmune disorders with age (10), all assays were performed on mice 3-5 wk of age.

Preparation of IEL. Whole small intestine was removed from mice and the lumen flushed with MEM medium. The intestine was incised to expose the epithelial layer, and pieces ~1 cm in length were shaken in 35 ml of MEM at room temperature for 30 min to displace IEL. Cells were passed through gauze to remove intestinal debris and centrifuged at 1,000 rpm (250 g) for 5 min. Cells were resuspended in 8 ml of 44% Percoll (Sigma Chemical Co., St. Louis, MO), overlayed onto 67.5% Percoll, and centrifuged at 2,100 rpm (600 g) for 20 min. The interface was recovered, washed, and resuspended in alpha MEM containing 10% FCS and Hepes (CM [complete medium]). The total number of cells isolated at this step was counted as the total IEL cell number.

Induction of NK Activity In Vivo. Mice were injected intraperitoneally with 0.1 µg of polyinosinic:polycytidilic acid (poly[I]: poly[C], Pharmacia, Upsala, Sweden) in 0.2 ml of PBS on day 0 and day 1. Spleens were removed on day 2, and mononuclear cells (MNC) were isolated by density gradient centrifugation using Lympholite M (Cedarlane, Hornby, Ontario).

Induction of NK Activity In Vitro. Spleen MNC isolated by density gradient centrifugation were incubated with 10 ng/ml murine recombinant IL-12 (Genzyme, Cambridge, MA) for 18 h in CM. After two washes in CM, viable MNC were counted and cytolytic activity was assessed.

NK Cytotoxic Assay. MNC obtained after in vivo or in vitro induction of NK activity were added to V-bottomed plates (Microwell; Nunc, Raskilde, Denmark) in complete medium. The NKsensitive Moloney leukemia virus-induced mouse lymphoma cell line YAC-1 was grown in CM, labeled with Na251CrO4 (NEN, Boston, MA) (35 µCi/106 cells), and added to wells containing effector cells. Target cell lysis was determined after a 4-h incubation by measurement of 51Cr release using the following formula: percentage specific lysis = (a - b / c - b) × 100%, where a = test release, b = spontaneous release, and c = release in the presence of 1% SDS. Spontaneous release was always <10%.

mAbs. mAbs used in this study were as follows: anti-mouse CD3epsilon (FITC-conjugated, clone 145-2C11), anti-mouse Thy-1.2 (biotin-conjugated, clone 53-2.1), anti-mouse CD4 (FITC-conjugated, clone RM4-5), anti-mouse CD8alpha (biotin-conjugated, clone 53-6.7), anti-mouse CD8beta (PE-conjugated, clone 53-5.8), anti-mouse TCRalpha beta (PE-conjugated, clone H57-597), anti-mouse TCRgamma delta (FITC-conjugated, clone GL3), anti-mouse NK1.1 (PE-conjugated, clone PK136), and anti-mouse Ly-49A (PEconjugated, clone A1). All mAbs were from PharMingen (San Diego, CA).

Flow Cytometry. IEL cells, peripheral blood (PB) leukocytes, or spleen MNC from poly(I):poly(C)-treated or untreated mice were resuspended in 0.1 ml of PBS containing 1% BSA and 0.1% sodium azide, and incubated with 2 µl of anti-CD32/CD16 (Fc block; PharMingen) for 10 min at room temperature. Cells were subsequently incubated on ice with mAbs for 30 min and analyzed by flow cytometry (FACScalibur®; Becton Dickinson, San Jose, CA) using CELLQuestTM software (Becton Dickinson). Viable lymphocytes were gated on the basis of forward and side scatter characteristics. A total of 10,000 gated events was analyzed for each sample.

Evaluation of Cell Numbers in PB and Spleen. Total numbers of leukocytes in EDTA-anticoagulated blood and density gradient (Lympholite M) purified spleen MNC were assessed by staining with Turk's stain.


Results and Discussion

IEL cells, a unique subset of lymphocytes located between the epithelial cells of the gut mucosa, have been postulated to play a key role in mucosal immunity (15). IEL constitute the most abundant extrathymic T lymphocyte pool and exist as a heterogeneous population (16). In the mouse, approximately half of IEL cells resemble peripheral T cells in that they are Thy-1+ and TCRalpha beta +. While most of these IEL are CD8alpha beta +, some CD4+ and a few doublepositive cells are also present. In contrast, the remaining IEL population expresses the CD8alpha alpha homodimer and may be either Thy-1+ or Thy-1-, and TCRalpha beta + or TCRgamma delta +. Although it is generally believed that TCRgamma delta IEL develop in situ within the intestine, some controversy exists regarding the origin of the various IEL subsets expressing TCRalpha beta (17). The evidence does, however, point to an extrathymic origin for TCRalpha beta IEL expressing CD8alpha alpha (18). This heterogeneity within the IEL compartment has made the exact determination of IEL function and development difficult, and little is known concerning the requirements for the normal differentiation of these lymphocyte populations.

IEL have been found to express the intermediate affinity form of the IL-2R (IL-2Rbeta gamma ) (19), and examination of IL-2Rbeta expression has shown that IEL with high and low levels of IL-2Rbeta can be identified (20). To address the role of IL-2Rbeta in IEL cell development, flow cytometric analyses of IEL obtained from IL-2Rbeta -/- and IL-2Rbeta +/- mice were performed. Despite an equivalent number of total IEL cells, a distinctly different population profile was observed in IL-2Rbeta -/- mice compared with that in their IL-2R+/- or wild-type littermates. As shown in both Fig. 1 and Table 1, IEL from normal mice comprise heterogeneous populations of TCRalpha beta + and TCRgamma delta + cells. However, IEL from IL2Rbeta -deficient mice showed a preponderance of TCRalpha beta + cells and a dramatic reduction in TCRgamma delta + cells. The normal ratio of alpha beta :gamma delta cells in IEL (shown here in IL-2Rbeta +/- mice) is ~2:1, but this ratio was dramatically increased to 9:1 in IL-2Rbeta -/- mice. The number of Thy-1- IEL cells was also profoundly decreased in the absence of IL-2Rbeta . In IL-2Rbeta +/- mice used as controls, more than half of both TCRalpha beta + and TCRgamma delta + IEL were negative for Thy-1. However, Thy-1- cells represented <5% of both alpha beta + and gamma delta + IEL in IL-2Rbeta -deficient mice. Immunohistological analysis revealed cells that stained positively with antiTCRalpha beta mAb, but not with anti-TCRgamma delta mAb (data not shown), confirming the reduced number of TCRgamma delta + IEL observed using FACS® analysis. Similar results have been reported for other cytokine receptor mutants. In IL-7Ralpha knockout mice, gamma delta T cells (including gamma delta IEL) failed to develop, whereas alpha beta T cells (including alpha beta IEL) were present in slightly reduced numbers, and NK cells were normal (21, 22; H. Kiyono, personal communication). The determination of gamma delta expression in spleen or lymph node cells has proven to be problematic in IL-2Rbeta -deficient mice because of the increased alpha beta T cell and granulocyte populations occurring in these mutants. Because alpha beta cells normally constitute only a small proportion of overall spleen and lymph node cells, at this time we cannot distinguish between a relative and real decrease in gamma delta cell numbers in the knockout mouse as a whole.


Fig. 1. Flow cytometric analysis of Thy-1, TCRalpha beta , and TCRgamma delta expression on IEL from heterozygous (IL-2Rbeta +/-) and homozygous (IL2Rbeta -/-) IL-2Rbeta -deficient mice. IEL isolated from IL-2Rbeta +/- or IL2Rbeta -/- mice were stained with anti-Thy-1 mAb, and anti-TCRalpha beta or anti-TCRgamma delta mAb, and viable cells were analyzed by flow cytometry. Numbers represent the percentage of total cells found in each quadrant.
[View Larger Version of this Image (74K GIF file)]

Table 1. Expression of TCR, Thy-1, CD8, and CD4 in IEL of IL-2Rbeta -deficient Mice


CD3+ CD3- (n = 4)
TCRalpha beta + (n = 4) TCRalpha beta + (n = 3) TCRgamma delta + (n = 3)
CD8alpha alpha + CD8alpha beta + CD4+ Thy-1+ Thy-1- Thy-1+ Thy-1-

IL-2Rbeta +/- 33.0 ± 5.0* 38.2 ± 8.9  4.5 ± 1.0 36.3 ± 7.8 24.0 ± 12.2 15.3 ± 4.0 23.3 ± 3.1 31.6 ± 13.7
IL-2Rbeta -/-  2.8 ± 2.1 56.0 ± 2.8 28.3 ± 1.0 91.3 ± 1.5 3.0 ± 1.0  7.5 ± 3.5  1.7 ± 3.5 34.4 ± 10.2

*  Numbers are mean ± SEM percentage of CD3+ cells (CD3+) or CD3- lymphocytes (CD3-) found in each quadrant as determined by FACS® analysis.

When TCRalpha beta + IEL were analyzed for the expression of CD8alpha and CD8beta , a significant reduction in CD8alpha +beta - (CD8alpha alpha ) cells was observed in IL-2Rbeta -/- IEL compared with IL-2Rbeta +/- IEL (Fig. 2). Thus, IEL in IL-2Rbeta -deficient mice can be characterized as lacking TCRgamma delta + and TCRalpha beta + CD8alpha alpha cells. Similar total numbers of IEL were recovered after density gradient centrifugation of intestinal cells in both IL-2Rbeta -/- mice (0.8 ± 0.2 × 106, n = 4) and IL-2Rbeta +/- mice (1.1 ± 0.2 × 106, n = 5). Only TCRalpha beta + CD8alpha beta + or CD4+ cells were not reduced in IL-2Rbeta -/- mice (Table 1). In fact, as previously reported (10), the ratio of CD4:CD8 cells was elevated in IL-2Rbeta -/- mice. These results clearly show that two subpopulations of IEL exist: an IL-2Rbeta -dependent population, characterized by expression of TCRalpha beta CD8alpha alpha and TCRgamma delta , and an IL2Rbeta -independent population, characterized by TCRalpha beta CD8alpha beta expression. Two distinct populations of IEL cells have been previously described (23), from which it was proposed that those IEL undergoing thymus-dependent development display the CD8beta + marker and those that develop independently of the thymus express the CD8alpha alpha homodimer. It has been postulated that this thymus-independent population differentiates from CD3- precursors present in the gut wall (24), and that expression of CD8alpha alpha on these cells is induced by the immediate gut microenvironment. The presence of similar numbers of CD3- cells in the IEL populations isolated from both IL-2Rbeta +/- and IL2Rbeta -/- mice suggests that the reduction in CD8alpha alpha + IEL observed in IL-2Rbeta -deficient animals is not the result of a lack of CD3- precursors in the gut wall, but rather due to a lack of differentiation of these cells into CD8alpha alpha + cells, possibly caused by a defect in gut microenvironment-IEL interaction. Therefore, we hypothesize that the establishment of a gut microenvironment that is permissive for the development of lymphocyte subsets of extrathymic origin is dependent on IL-15 and/or IL-2 through signaling via the IL-2Rbeta chain.


Fig. 2. Flow cytometric analysis of CD8alpha beta expression on TCRalpha beta + IEL from IL-2Rbeta -deficient mice. IEL isolated from IL-2Rbeta +/- or IL2Rbeta -/- mice were stained with anti-CD4, anti-CD8alpha , and anti-CD8beta mAb. Cells gated on TCRalpha beta + cells were analyzed for their expression of CD8alpha and CD8beta . Numbers represent the percentage of total cells found in each quadrant.
[View Larger Version of this Image (76K GIF file)]

The role of IL-2Rbeta in NK cell development and function was also investigated in this study. NK cells are lymphocytes capable of non-MHC-restricted cytotoxicity against virally infected and tumor cells (25), and activated NK cells are known to express both the high and intermediate affinity IL-2 receptors (26). Because both forms of the IL-2R contain the beta  chain, which is expressed at a high level in resting NK cells (3), and anti-IL-2Rbeta mAb treatment leads to long-term elimination of NK cells in vivo (27), it was thought that the IL-2R beta  chain might play a role in NK cell function and development.

NK cell-mediated cytotoxicity was evaluated using spleen MNC as a source of NK cells and the prototypic NK target cell line YAC-1. No cytotoxic activity was apparent in unstimulated spleen MNC of 3-5-wk-old wild-type or mutant mice (data not shown). To study in vivo induction of NK activity, mice were treated with the type I interferon inducer poly(I):poly(C). While substantial NK cell-mediated cytotoxic activity was induced in IL-2Rbeta +/- mice, no cytotoxic activity was apparent in spleen NK cells derived from IL-2Rbeta -/- mice (Fig. 3 A). To examine the activation of NK activity in vitro, spleen MNC from IL-2Rbeta +/- and IL-2Rbeta -/- mice were incubated overnight with IL-12. IL-12 induced significant cytolytic activity in MNC of IL2Rbeta +/- mice but was completely ineffective in inducing detectable NK cytolytic activity in IL-2Rbeta -/- MNC (Fig. 3 B). Analysis of IFN-gamma production (by ELISA [Intertest gamma ; Genzyme, Cambridge, MA]) in culture supernatants of spleen MNC incubated with IL-12 revealed a 270-fold increase in IFN-gamma production over unstimulated controls in IL-2Rbeta +/- cells, but only a 2-fold increase in IL-2Rbeta -/- cells (data not shown). These results strongly indicate an absence of functional NK cells in IL-2Rbeta -deficient mice.


Fig. 3. NK cell cytolytic activity and development in IL-2Rbeta -deficient mice. Top panels show lysis of YAC-1 target cells by (A) spleen MNC from poly(I):(C )-treated animals or (B) spleen MNC incubated in vitro with IL-12. IL-2Rbeta +/- MNC are represented by closed symbols; IL-2Rbeta -/- MNC are represented by open symbols. Data are shown as mean ± SEM for (A) five IL-2Rbeta +/- and five IL-2Rbeta /- mice and for (B) four IL-2Rbeta +/- and two IL-2Rbeta -/- mice, analyzed in two separate experiments. (C) Flow cytometric analysis of NK1.1 and CD3 expression on NK cells in IL-2Rbeta -deficient mice. PB cells from IL-2Rbeta +/- and IL2Rbeta -/- mice were stained with anti-NK1.1 and anti-CD3, and 10,000 viable lymphocytes were gated. Numbers represent the percentage of NK1.1+ cells in the gated population for a representative individual from each group.
[View Larger Version of this Image (30K GIF file)]

To determine whether the defect in IL-2Rbeta -/- NK cell cytotoxic activity was due to a functional inactivation of NK cells or to a block in NK cell development, NK cell numbers were evaluated using flow cytometry (as judged by the presence of NK1.1+/CD3- cells). Absolute numbers of PB leukocytes and spleen MNC in IL-2Rbeta -deficient mice were reduced compared with heterozygous controls (Table 2). Flow cytometric analysis of lymphocytes from PB (Fig. 3 C; Table 2) and spleen MNC (Table 2) in untreated mice revealed a fivefold decrease in NK1.1+/ CD3- cells in IL-2Rbeta -deficient mice. Similar results were obtained for PBL and spleen MNC obtained from poly(I): poly(C)-treated animals (data not shown). IL-2Rbeta -/- mice also displayed an absence of Ly-49A+ cells both in peripheral blood and spleen (data not shown), confirming the absence of NK cells in these mice.

Table 2. Occurence of CD3+ and NK1.1+ Cells in PB and Spleen MNC of IL-2Rbeta -deficient Mice


PB Spleen MNC
Total leukocytes (× 106 ml PB) (n = 3) CD3+ NK1.1- (Percent, n = 13) NK1.1+ CD3- Total MNC (× 106 ml spleen) (n = 3) CD3+ NK1.1- (Percent, n = 6) NK1.1+ CD3-

IL-2Rbeta +/- 8.6 ± 0.9 *33.9 ± 4.4 *2.3 ± 0.3 74.3 ± 5.9 Dagger 35.6 ± 4.0 Dagger 2.2 ± 0.4
IL-2Rbeta -/- 2.1 ± 0.5     53.2 ± 4.0     0.5 ± 0.01 24.8 ± 4.6   48.5 ± 5.8     0.5 ± 0.01

*  Numbers are mean ± SEM percentage of total leukocytes found in each quadrant as determined by FACS® analysis.
Dagger Numbers are mean ± SEM percentage of total spleen MNC found in each quadrant as determined by FACS® analysis.

The IL-2Rbeta -deficient mice used in this study were generated using A129/J mice, a strain that is known to be negative for the NK1.1 surface marker of NK cells (28). It is very unlikely that the absence of detectable NK1.1 surface marker on IL-2Rbeta -/- cells was due to the presence of A129/J background in these mice, because they had been backcrossed into a C57BL/6 background five times. In all littermates examined during the course of these experiments, IL-2Rbeta +/- mice showed consistent numbers of NK1.1+ cells, whereas IL-2Rbeta -/- mice always displayed very low levels of NK1.1 staining. Inadvertent deletion of the NK1.1 gene due to colocalization with the the IL-2Rbeta gene can also be dismissed, since the NK gene complex (in which the NK1.1, Ly-49, LGL-1, and NKR-P1 genes are clustered) is located on distal mouse chromosome 6 (29), whereas the IL-2Rbeta gene is localized on mouse chromosome 15 (30).

Although the beta  chain subunit is essential for IL-2-mediated signal transduction, a defect in IL-2Rbeta expression does not affect the development of classical T cells (10). Several studies have indicated that in both mouse and human, progenitor cells capable of differentiation into either T lymphocytes or NK cells are present in the thymus (31). Those progenitors remaining within the thymus differentiate into T cells, while those developing extrathymically become NK cells (31), implying that the immediate microenvironment provides the required signals for a specific differentiation pathway. Within the murine fetal thymus, this bipotential progenitor cell population largely expresses not only IL-2Rbeta (34, 35) but also IL-15Ralpha messenger RNA (34), suggesting that these cells can respond to both IL-2 and IL-15.

It has been demonstrated that IL-2-deficient mice have reduced but inducible NK cell-mediated cytotoxicity (36), suggesting the existence of other compensatory IL-2R binding molecules that may play a role in NK cell development. IL-15 shares many of the properties of IL-2 in its potentiation of NK cell cytokine production and cytotoxic activity (14), and the IL-2Rbeta chain is common to the IL-2 and IL-15 receptors (8). The decrease in NK cell number apparent in both IL-2Rbeta and gamma  chain knockout mice, together with the demonstration that IL-2 is dispensable for NK cell development (36), suggests that IL-15 may be the more critical molecule for NK cell development. This is supported by the observation that IL-2Rbeta -expressing fetal thymic bipotential T/NK progenitor cells cultured with IL-15 differentiated into functional NK cells capable of lysing YAC-1 target cells (34). High doses of IL-2 also induced differentiation into functional NK cells but did not result in the same level of proliferation (34). It has also recently been reported that IL-15 is a maturation factor for NK cells in vitro, capable of rescuing the development of functional NK cells from mice in which the bone marrow microenvironment (essential for the development of fully functional NK cells) has been disrupted (37).

Investigation of the effect of IL-15 on the differentiation of bipotential T/NK progenitor cells in fetal thymic organ culture has shown that low doses of IL-15, but not IL-2, induce the expansion of TCRgamma delta CD8alpha alpha T cells from this progenitor population (34). This effect is blocked by the addition of anti-IL-2Rbeta mAb. Similarly, treatment in utero with anti-IL-2Rbeta mAb blocks the development of Vgamma 3+ dendritic epidermal cells (38), which are the developmental progeny of Vgamma 3+ fetal thymocytes (39). That this maturation may depend on IL-15-mediated (rather than IL-2- mediated) signaling through the IL-2Rbeta chain is suggested by the observation that Vgamma 3+ dendritic epidermal cells are present in IL-2-deficient mice (40). These results, taken together with the reduction in TCRgamma delta CD8alpha alpha IEL observed in this study, point to the importance of IL-2Rbeta in the development of extrathymic TCRgamma delta lymphocytes, possibly as a component of the IL-15R.

Given that fetal thymic T/NK progenitors require IL2Rbeta expression for differentiation into gamma delta and NK cells (34), it is possible that the block in development of TCRalpha beta CD8alpha alpha and TCRgamma delta IEL observed in IL-2Rbeta -deficient mice lies at an early stage of progenitor differentiation within the thymus. However, the presence of these IEL subsets in athymic mice (41) suggests that it is the gut microenvironment itself that determines the surface phenotype of the cell, and that in the absence of appropriate IL-2Rbeta -mediated signaling in this location, extrathymic IEL cannot develop. Likewise, although NK precursors are found in the thymus, NK cell differentiation does not require the presence of a thymus, suggesting that any developmental block seen in IL-2Rbeta -deficient mice is probably associated with a block in development or differentiation in the periphery, possibly within the bone marrow microenvironment. A subset of IEL expressing surface markers characteristic of NK cells and capable of natural killing and antibody-dependent cell-mediated cytotoxicity has recently been described (42). Interestingly, this subset is limited exclusively to the thymus-independent TCRalpha beta CD8alpha alpha or TCRgamma delta population. Therefore, it is fascinating to note that two distinct lineages of lymphocyte capable of natural killing, the thymus-independent IEL (which can now be classed as NK-T IEL), and classical NK cells, are both critically dependent on IL-2Rbeta for their normal development.

In conclusion, our observation that TCRalpha beta CD8alpha alpha IEL, TCRgamma delta IEL, and NK cells fail to develop in IL-2Rbeta - deficient mice is supportive of a major role for IL-15 in the development of these extrathymic lymphocyte subsets. The alpha  chain of the IL-15 receptor has recently been identified and cloned (43), manipulation of which may help to clarify the situation. The generation of a mouse with a gene-targeted disruption of the IL-15 gene will no doubt elucidate further the role of IL-15 in NK and IEL cell development.


Footnotes

Address correspondence to Dr. Tak W. Mak, Amgen Institute, 620 University Avenue, Toronto, Ontario, Canada M5G 2C1. H. Suzuki's present address is Department of Immunology, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 464, Japan. H. Takimoto's present address is Department of Immunology, Medical Institute of Bioregulation, Kyushu University 69, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812, Japan.

Received for publication 12 September 1996

   H. Suzuki was supported by a post doctoral fellowship from the Cancer Research Institute, and T.W. Mak by the Medical Research Council of Canada.
   The first two authors contributed equally to this study.
   1 Abbreviations used in this paper: CM, complete medium; IEL, intraepithelial cells; MNC, mononulear cells; PB, peripheral blood.

We thank Drs. H.-W. Mittrücker, J. Penninger, and T. Ohteki for critically reviewing the manuscript and Dr. M.E. Saunders for scientific editing.


References

1. Waldmann, T.A.. 1993. The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunol. Today. 14: 264-270 [Medline] .
2. Begley, C.G., J.D. Burton, M. Tsudo, B.H. Brownstein, J.L. Ambrus, and T.A. Waldmann. 1990. Human beta  lymphocytes express the p75 component of the interleukin 2 receptor. Leuk. Res. 14: 263-271 [Medline] .
3. Nishikawa, K., S. Saito, T. Mori, Y. Kato, N. Narita, M. Ichijo, Y. Ohashi, T. Takeshita, and K. Sugamura. 1990. Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets. Int. Immunol. 2: 481-486 [Medline] .
4. Djeu, J.Y., J.H. Liu, S. Wei, H. Rui, C.A. Pearson, W.J. Leonard, and D.K. Blanchard. 1993. Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J. Immunol. 150: 960-970 [Abstract/Free Full Text] .
5. Espinoza-Delgado, I., J.R. Ortaldo, R. Winkler-Pickett, K. Sugamura, L. Varesio, and D.L. Longo. 1990. Expression and role of p75 interleukin 2 receptor on human monocytes. J. Exp. Med. 171: 1821-1826 [Abstract] .
6. Minami, Y., T. Kono, T. Miyazaki, and T. Taniguchi. 1993. The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 11: 245-268 [Medline] .
7. Taniguchi, T., and Y. Minami. 1993. The IL-2/IL-2 receptor system: a current overview. Cell. 73: 5-8 [Medline] .
8. Grabstein, K.H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M.A. Schoenborn, M. Ahdieh, et al . 1994. Cloning of a T cell growth factor that interacts with the beta  chain of the interleukin-2 receptor. Science (Wash. DC). 264: 965-968 [Medline] .
9. Willerford, D.M., J. Chen, J.A. Ferry, L. Davidson, A. Ma, and F.W. Alt. 1995. Interleukin-2 receptor alpha  chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 3: 521-530 [Medline] .
10. Suzuki, H., T.M. Kündig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J.J.L. Simard, P.S. Ohashi, H. Griesser, et al . 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta . Science (Wash. DC). 268: 1472-1476 [Medline] .
11. DiSanto, J.P., W. Müller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma  chain. Proc. Natl. Acad. Sci. USA. 92: 377-381 [Abstract] .
12. Noguchi, M., H. Yi, H.M. Rosenblatt, A.H. Filipovich, S. Adelstein, W.S. Modi, O.W. McBride, and W.J. Leonard. 1993. Interleukin-2 receptor gamma  chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 73: 147-157 [Medline] .
13. Conley, M.E.. 1992. Molecular approaches to the analysis of X-linked immunodeficiencies. Annu. Rev. Immunol. 10: 215-238 [Medline] .
14. Carson, W.E., J.G. Giri, M.J. Lindenmann, M.L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M.A. Caliguri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180: 1395-1403 [Abstract] .
15. Fujihashi, K., T. Taguchi, J.R. McGhee, J.H. Eldridge, M.G. Bruce, D.R. Green, B. Singh, and H. Kiyono. 1990. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance. J. Immunol. 145: 2010-2019 [Abstract/Free Full Text] .
16. Poussier, P., and M. Julius. 1994. Thymus independent T cell development and selection in the intestinal epithelium. Annu. Rev. Immunol. 12: 521-553 [Medline] .
17. Poussier, P., and M. Julius. 1994. Intestinal intraepithelial lymphocytes: the plot thickens. J. Exp. Med. 180: 1185-1189 [Medline] .
18. Rocha, B., D. Guy-Grand, and P. Vassalli. 1995. Extrathymic T cell differentiation. Curr. Opin. Immunol. 7: 235-242 [Medline] .
19. Kawamoto, Y., K. Sasaki, Y. Kato, K. Kojima, T. Tsuji, and A. Miyama. 1996. Rapid killing of murine lymph node T blasts by intestinal intraepithelial lymphocytes in vitro. Eur. J. Immunol. 26: 653-658 [Medline] .
20. Ohtsuka, K., T. Iiai, H. Watanabe, T. Tanaka, M. Miyasaka, K. Sato, H. Asakura, and T. Abo. 1994. Similarities and differences between extrathymic T cells residing in mouse liver and intestine. Cell. Immunol. 153: 52-66 [Medline] .
21. He, Y.-W., and T.R. Malek. 1996. Interleukin-7 receptor alpha  is essential for the development of gamma delta + T cells, but not natural killer cells. J. Exp. Med. 184: 289-293 [Abstract] .
22. Maki, K., S. Sunaga, Y. Komagata, Y. Kodaira, A. Mabuchi, H. Karasuyama, K. Yokomuro, J.-I. Miyazaki, and K. Ikuta. 1996. Interleukin 7 receptor-deficient mice lack gamma delta T cells. Proc. Natl. Acad. Sci. USA. 93: 7172-7177 [Abstract/Free Full Text] .
23. Guy-Grand, D., B. Rocha, P. Mintz, M. Malassis-Seris, F. Selz, B. Malissen, and P. Vasalli. 1994. Different use of T cell receptor transducing modules in two populations of gut intraepithelial lymphocytes are related to distinct pathways of T cell differentiation. J. Exp. Med. 180: 673-679 [Abstract] .
24. Rocha, B., P. Vassalli, and D. Guy-Grand. 1994. Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice. J. Exp. Med. 180: 681-686 [Abstract] .
25. Trinchierei, G.. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-386 [Medline] .
26. Phillips, J.H., T. Takeshita, K. Sugamura, and L.L. Lanier. 1989. Activation of natural killer cells via the p75 interleukin 2 receptor. J. Exp. Med. 170: 291-296 [Abstract] .
27. Tanaka, T., F. Kitamura, Y. Nagasaka, K. Kuida, H. Suwa, and M. Miyasaka. 1993. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta  chain monoclonal antibody in mice. J. Exp. Med. 178: 1103-1107 [Abstract] .
28. Giorda, R., E.P. Weisberg, T.K. Ip, and M. Trucco. 1992. Genomic structure and strain-specific expression of the natural killer receptor NKR-P1. J. Immunol. 149: 1631-1635 [Abstract/Free Full Text] .
29. Yokoyama, W.M., and W.E. Seaman. 1993. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11: 613-635 [Medline] .
30. Malek, T.R., V. Vincek, B. Gatalica, and M. Bucan. 1993. The IL-2 receptor beta chain gene (IL-2Rbeta ) is closely linked to the PDGFbeta locus on mouse chromosome 15.  Immunogenetics. 38: 154-156 [Medline] .
31. Rodewald, H.R., P. Moingeon, J.L. Lucich, C. Dosion, P. Lopez, and E.L. Reinherz. 1992. A population of early fetal thymocytes expressing Fcgamma RII/III contain precursors of T lymphocytes and natural killer cells. Cell. 69: 139-150 [Medline] .
32. Sanchez, M.J., M.O. Muench, M.G. Roncarolo, L.L. Lanier, and J.H. Phillips. 1994. Identification of a common T/natural killer cell progenitor in human fetal thymus. J. Exp. Med. 180: 569-576 [Abstract] .
33. Sanchez, M.J., H. Spits, L.L. Lanier, and J.H. Phillips. 1993. Human natural killer cell committed thymocytes and their relation to the T cell lineage. J. Exp. Med. 178: 1857-1866 [Abstract] .
34. Leclerque, G., V. Debacker, M. DeSmedt, and J. Plum. 1996. Differential effects of interleukin-15 and interleukin-2 on differentiation of bi-potential T/natural killer progenitor cells. J. Exp. Med. 184: 325-226 [Abstract] .
35. Falk, I., C.N. Levelt, and K. Eichmann. 1993. Lineage relationships of the fetal thymocyte subset that expresses the beta  chain of the interleukin-2 receptor. Eur. J. Immunol. 23: 3373-3376 [Medline] .
36. Kundig, T.M., H. Schorle, M.F. Bachmann, H. Hengartner, R.M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science (Wash. DC). 262: 1059-1061 [Medline] .
37. Puzanov, I.J., M. Bennett, and V. Kumar. 1996. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J. Immunol. 157: 4282-4285 [Abstract] .
38. Tanaka, T., Y. Takeuchi, T. Shiohara, F. Kitamuro, Y. Nagaska, K. Hamamura, H. Yagita, and M. Miyasaka. 1992. In utero treatment with monoclonal antibody to IL-2 receptor beta  chain completely abrogates development of Thy-1+ dendritic epidermal cells. Int. Immunol. 4: 487-491 [Abstract] .
39. Havran, W.L., and J.P. Allison. 1990. Origin of Thy-1+ dendritic epidermal cells of adult mice from fetal thymic precursors. Nature (Lond.). 344: 68-70 [Medline] .
40. Schimpl, A., T. Hünig, A. Elbe, I. Berberich, S. Krämer, H. Merz, A.C. Feller, B. Sadlack, H. Schorle, and I. Horak. 1994. Development and function of the immune system in mice with targeted disruption of the IL-2 gene. In Transgenics and Targeted Mutagenesis in Immunology. H. Bluethman and P. Ohasi, editors. Academic Press, London, UK. 191-201.
41. Rocha, B., P. Vassalli, and D. Guy-Grand. 1992. The extrathymic T-cell development pathway. Immunol. Today. 13: 449-454 [Medline] .
42. Guy-Grand, D., B. Cuenod-Jabri, M. Malassis-Seris, F. Selz, and P. Vassalli. 1996. Complexity of the mouse gut T cell immune system: identification of two distinct natural killer T cell intraepithelial lineages. Eur. J. Immunol. 26: 2248-2256 [Medline] .
43. Giri, J.G., S. Kumaki, M. Ahdieh, D.J. Friend, A. Loomis, K. Shanebeck, R. DuBose, D. Cosman, L.S. Park, and D.M. Anderson. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO (Eur. Mol. Biol. Organ.) J. 14: 3654-3663 [Abstract] .

Copyright © 1997 by The Rockefeller University Press.